d-wise provides clinical data management and technology consulting focused on clinical trial analytics and transparency services, self-described as domain leaders in biometrics and anonymization technology.

d-wise

Research Services

Instem

d-wise | 3,224 followers on LinkedIn. We help Pharmaceutical, Biotech, Contract Research Organizations, and Medical Device companies navigate technology change in pursuit of human health and wellbeing.  For almost two decades, the world’s Life Science companies have trusted d-wise to innovate their Clinical Trial and Transparency systems and processes.

Doing More.

Metric
Company Name	d-wise
Symbol
MSH ID	COM:D-WISE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Clinical Research
Country	US
Stage
Employee Count
Website	d-wise.com
LinkedIn	d-wise-technologies-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	517
Web Traffic Growth	10.24
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

D-WI

COM:D-WISE

d-wise

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue